Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which?-Reference-Cited by-同舟云学术

Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which?

Published:2020-07-10 Issue:8 Volume:19 Page:1025-1030
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Grandi Giovanni¹^ORCID,Caroli Martina¹,Cortesi Laura²,Toss Angela²³,Tazzioli Giovanni¹⁴,Facchinetti Fabio¹

Affiliation:

1. Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy

2. Department of Oncology and Haematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy

3. Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy

4. Oncologic Breast Surgery Unit, Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2020.1791818

Reference30 articles.

1. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

2. Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review

3. Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)

4. National Comprehensive Cancer Network (NCCN) guidelines. Hereditary Breast and/or Ovarian Cancer. cited 2020 Mar 10 Available from https://www.nccn.org/professionals/physician_gls/default.aspx#detection

5. Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Menopausia quirúrgica en pacientes con mutación BRCA, el rol de la terapia hormonal;Revista del Hospital Italiano de Buenos Aires;2023-09-29

2. Phyto-progestins for the treatment of abnormal uterine bleeding without organic cause in women at high risk for breast cancer and breast cancer survivors: a prospective, pilot study;Gynecological Endocrinology;2023-07-26

3. Molecular actions of sex hormones in the brain and their potential treatment use in anxiety disorders;Frontiers in Psychiatry;2022-09-08

4. Contraception and Hormone Replacement Therapy in Healthy Carriers of Germline BRCA1/2 Genes Pathogenic Variants: Results from an Italian Survey;Cancers;2022-07-15

5. Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis;Breast Cancer Research and Treatment;2021-11-03